BeyondSpring logo

BeyondSpring

BYSI | NASDAQ
Chart Builder DCF Calculator
$0.58
-$0.02 (-3.53%)
At close: Nov 16, 2026, 4:00 PM ET
$0.58
$0.00 (-0.21%)
After-hours: Nov 16, 2026, 4:10 PM ET
-3.53%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
26.5
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #887/1021 (Top 87%)

Key Statistics

Market Data

Market Cap $23.8M
1D Range
0.55 0.61
52W Range
0.43 2.35

Valuation (TTM)

PE -2.90
PB 1.56
EV/EBITDA -2.81

Valuation (NTM)

Forward PE 0.30
Forward PEG -0.04
Price Target $0.00
Loading financial charts...

Profile

BeyondSpring Inc. is a clinical-stage biopharmaceutical company focused on developing novel cancer treatments. Its flagship product is Plinabulin, a selective immune-modulating and microtubule-binding...

Sector Healthcare
Industry Biotechnology
Employees 44
IPO Date Mar 9, 2017
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Next Earnings
Dec 17, 2026
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.